NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to fund efforts to develop new resources that investigators focused on pharmacogenomics can use to speed up their research activities or to implement them into practice.

The National Institutes of Health said in a funding announcement today that these enabling resources will provide activities, services, platforms, or methods that meet specific scientific needs and will benefit the entire pharmacogenomics research field.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.